Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy

被引：0
|
作者：
Li, Qiang [1 ,2 ]
Yang, Zhihuan [1 ,2 ]
Fang, Kuo [1 ,2 ]
Wei, Shuning [1 ,2 ]
Sun, Jiali [1 ,2 ]
Liu, Wei [1 ,2 ]
Chen, Xiaojuan [1 ,2 ]
Huang, Wenyang [1 ,2 ]
Zhang, Guangji [1 ,2 ]
Shi, Yin [1 ,2 ]
Liu, Yuntao [1 ,2 ]
Gong, Xiaoyuan [1 ,2 ]
Liu, Fang [1 ,2 ]
Zhou, Xueli [1 ,2 ]
Wang, Jianxiang [1 ,2 ]
Wang, Ying [1 ,2 ,3 ,4 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Tianjin Key Lab Cell Therapy Blood Dis, State Key Lab Expt Hematol,Natl Clin Res Ctr Blood, Tianjin 300020, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin 300020, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin 300020, Peoples R China
来源：
BLOOD SCIENCE | 2023年 / 5卷 / 01期
关键词：
D O I：
10.1097/BS9.0000000000000137
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：62 / 65
页数：4
相关论文
共 50 条
  • [31] Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy
    Chou, Cassie K.
    Turtle, Cameron J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 653 - 664
  • [32] GENOMIC DRIVERS OF LARGE B-CELL LYMPHOMA RESISTANCE TO CD19 CAR-T THERAPY
    Jain, Michael
    Ziccheddu, Bachisio
    Coughlin, Caroline
    Faramand, Rawan
    Griswold, Anthony
    Reid, Kayla
    Landgren, Ola
    Locke, Frederick
    Maura, Francesco
    Davila, Marco
    Schatz, Jonathan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A703 - A703
  • [33] Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation
    Xing-yu Cao
    Jing-jing Li
    Pei-hua Lu
    Kai-yan Liu
    International Journal of Hematology, 2022, 116 : 315 - 329
  • [34] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CART therapy
    An, Lihong
    Lin, Yuehui
    Deng, Biping
    Yin, Zhichao
    Zhao, Defeng
    Ling, Zhuojun
    Wu, Tong
    Zhao, Yongqiang
    Chang, Alex H.
    Tong, Chunrong
    Liu, Shuangyou
    BMC CANCER, 2022, 22 (01)
  • [35] Tandem CD19/CD22 Dual Targets CAR-T Cells Therapy Obtains Superior CR Rate Than Single CD19 CAR-T Cells Infusion As Well As Sequential CD19 and CD22 CAR-T Cells Infusion for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients
    Liu, Sining
    Zhang, Xinyue
    Dai, Haiping
    Cui, Qingya
    Cui, Wei
    Yin, Jia
    Li, Zheng
    Xue, Shengli
    Yang, Chunxiu
    Yang, Xiao
    Qiu, Huiying
    Miao, Miao
    Chen, Suning
    Jin, Zhengming
    Fu, Chengcheng
    Li, Caixia
    Sun, Aining
    Han, Yue
    Wang, Ying
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2021, 138
  • [36] Clinical Trial of CD19 CAR-T Cell Therapy with non-virus Vector System
    Takahashi, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S3 - S3
  • [37] CD19 CAR-T Outcomes in Patients with EBV-Positive DLBCL
    Nair, Ranjit
    Ayers, Amy
    Nastoupil, Loretta J.
    Gunther, Jillian R.
    Fayad, Luis
    Fowler, Nathan H.
    Miranda, Roberto N.
    Hagemeister, Fredrick B.
    Lee, Hun Ju
    Rodriguez, Maria Alma
    Steiner, Raphael
    Strati, Paolo
    Nieto, Yago
    Ramdial, Jeremy L.
    Chihara, Dai
    Wang, Michael L.
    Castillo, Luis E. Malpica
    Saini, Neeraj
    Jain, Preetesh
    Pinnix, Chelsea C.
    Dabaja, Bouthaina S.
    Green, Michael R.
    Flowers, Christopher R.
    Medeiros, L. Jeffrey
    Marques-Piubelli, Mario L.
    Vega, Francisco
    Noorani, Mansoor
    Ahmed, Sairah
    Westin, Jason
    Neelapu, Sattva S.
    Feng, Lei
    Iyer, Swaminathan Padmanabhan
    BLOOD, 2022, 140 : 3800 - 3802
  • [38] Long-Term Safety and Efficacy of CD19 Humanized Selective CAR-T Therapy in B-ALL Patients Who Have Previously Received Murine-Based CD19 CAR-T Therapy
    Zhao, Yu
    Zhang, Jianping
    Yang, Junfang
    Wu, Huantong
    Chen, Yao
    Li, Nannan
    Liu, Zhongfeng
    Wang, Xuan
    Liu, Weihua
    Zhang, Guangji
    Zhou, Bin-Bing Stephen
    Lu, Peihua
    Chen, Zhiguo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Impaired mRNA Based COVID-19 Vaccine Response in Patients with B-Cell Malignancies after CD19 Directed CAR-T Cell Therapy
    Dahiya, Saurabh
    Luetkens, Tim
    Avila, Stephanie
    Dahiya, Saurabh
    Margiotta, Philip
    Hankey, Kim
    Lesho, Patricia
    Bauman, Sherri
    Smith, Nancy
    Ruehle, Kathleen
    Lee, Seung-Tae
    Law, Jennie Y.
    Baddley, John
    Kocoglu, Mehmet Hakan
    Yared, Jean A.
    Hardy, Nancy M.
    Rapoport, Aaron P.
    Atanackovic, Djordje
    BLOOD, 2021, 138
  • [40] BsAbs before CD19 CAR-T full ahead!
    Riedell, Peter A.
    BLOOD, 2024, 144 (03) : 249 - 251
12345